{"id": "article-155518_0", "title": "Lymphocytic Esophagitis -- Introduction", "content": "Initially described by Rubio et al in 2006, lymphocytic esophagitis (LE) is a rare subtype of chronic esophagitis with a unique histologic phenotype characterized by increased peripapillary intraepithelial lymphocytes in the absence or minimal presence of intraepithelial granulocytes. [1] The rising incidence of LE is likely secondary to raising awareness of this condition among clinicians and pathologists and the increased frequency of performing esophageal biopsies in the clinical investigation of esophageal dysphagia. The significant efforts of researchers worldwide have led to better characterization of LE's clinical, endoscopic, and histological features.", "contents": "Lymphocytic Esophagitis -- Introduction. Initially described by Rubio et al in 2006, lymphocytic esophagitis (LE) is a rare subtype of chronic esophagitis with a unique histologic phenotype characterized by increased peripapillary intraepithelial lymphocytes in the absence or minimal presence of intraepithelial granulocytes. [1] The rising incidence of LE is likely secondary to raising awareness of this condition among clinicians and pathologists and the increased frequency of performing esophageal biopsies in the clinical investigation of esophageal dysphagia. The significant efforts of researchers worldwide have led to better characterization of LE's clinical, endoscopic, and histological features."}
{"id": "article-155518_1", "title": "Lymphocytic Esophagitis -- Introduction", "content": "The clinical presentation of LE is variable and may include dysphagia, dyspepsia, nausea,\u00a0or chest pain. Frequently diagnosed in older women, LE is associated with a history of tobacco use,\u00a0gastroesophageal reflux disease (GERD), and achalasia.", "contents": "Lymphocytic Esophagitis -- Introduction. The clinical presentation of LE is variable and may include dysphagia, dyspepsia, nausea,\u00a0or chest pain. Frequently diagnosed in older women, LE is associated with a history of tobacco use,\u00a0gastroesophageal reflux disease (GERD), and achalasia."}
{"id": "article-155518_2", "title": "Lymphocytic Esophagitis -- Introduction", "content": "This activity reviews the etiology, epidemiology, clinical characteristics, diagnosis, management, and complications of this rare but emerging subtype of\u00a0chronic esophagitis. It highlights the role of the interprofessional healthcare team in caring for patients with this gastrointestinal disorder.", "contents": "Lymphocytic Esophagitis -- Introduction. This activity reviews the etiology, epidemiology, clinical characteristics, diagnosis, management, and complications of this rare but emerging subtype of\u00a0chronic esophagitis. It highlights the role of the interprofessional healthcare team in caring for patients with this gastrointestinal disorder."}
{"id": "article-155518_3", "title": "Lymphocytic Esophagitis -- Etiology", "content": "Lymphocytic esophagitis is a rare subtype of chronic esophagitis, and the etiology is unknown. It is unclear whether\u00a0LE is a unique primary inflammatory esophageal disease or merely a marker of an underlying esophageal or systemic immune-mediated disease process. [2] However, with predominant clinical features such as persistent dysphagia,\u00a0the suggestion of\u00a0esophageal strictures documented during endoscopic evaluation, and histopathologic evidence consistent with lymphocytosis, LE is likely a chronic inflammatory disorder of the esophagus. [3] Extensive prospective studies are required to evaluate the natural history of LE.", "contents": "Lymphocytic Esophagitis -- Etiology. Lymphocytic esophagitis is a rare subtype of chronic esophagitis, and the etiology is unknown. It is unclear whether\u00a0LE is a unique primary inflammatory esophageal disease or merely a marker of an underlying esophageal or systemic immune-mediated disease process. [2] However, with predominant clinical features such as persistent dysphagia,\u00a0the suggestion of\u00a0esophageal strictures documented during endoscopic evaluation, and histopathologic evidence consistent with lymphocytosis, LE is likely a chronic inflammatory disorder of the esophagus. [3] Extensive prospective studies are required to evaluate the natural history of LE."}
{"id": "article-155518_4", "title": "Lymphocytic Esophagitis -- Epidemiology", "content": "Knowledge of the natural history of\u00a0LE is limited, given the relatively few studies of the condition. The incidence of\u00a0LE has been reported to be 0.1% of total esophageal biopsies based on the results of a large pilot study in the United States of more than 40,000 patients. [4] Worldwide demographic data on the incidence of\u00a0LE is limited.", "contents": "Lymphocytic Esophagitis -- Epidemiology. Knowledge of the natural history of\u00a0LE is limited, given the relatively few studies of the condition. The incidence of\u00a0LE has been reported to be 0.1% of total esophageal biopsies based on the results of a large pilot study in the United States of more than 40,000 patients. [4] Worldwide demographic data on the incidence of\u00a0LE is limited."}
{"id": "article-155518_5", "title": "Lymphocytic Esophagitis -- Epidemiology", "content": "The signs and symptoms of\u00a0LE mimic those of eosinophilic esophagitis; both are definitively diagnosed via endoscopic esophageal biopsy. Evaluations for eosinophilic esophagitis have been steadily increasing, and this increased number of endoscopic esophageal biopsies is presumed to be the reason behind the increasing incidence of LE diagnoses.", "contents": "Lymphocytic Esophagitis -- Epidemiology. The signs and symptoms of\u00a0LE mimic those of eosinophilic esophagitis; both are definitively diagnosed via endoscopic esophageal biopsy. Evaluations for eosinophilic esophagitis have been steadily increasing, and this increased number of endoscopic esophageal biopsies is presumed to be the reason behind the increasing incidence of LE diagnoses."}
{"id": "article-155518_6", "title": "Lymphocytic Esophagitis -- Epidemiology", "content": "Initial studies of LE reported its association with immunologic conditions such as rheumatologic disorders, common variable immunodeficiency, and Crohn disease, especially in pediatric patients. [1] [5] [6] [7] However, multiple subsequent studies evaluating the potential risk factors for\u00a0developing LE have reported that the disorder is more likely\u00a0in women in their sixth decade and\u00a0is significantly associated with underlying GERD, primary motility disorders such as achalasia, a history of tobacco use, certain allergies, hypothyroidism and the use of aspirin or statin medications. [8] [9] [10] [11] [12]", "contents": "Lymphocytic Esophagitis -- Epidemiology. Initial studies of LE reported its association with immunologic conditions such as rheumatologic disorders, common variable immunodeficiency, and Crohn disease, especially in pediatric patients. [1] [5] [6] [7] However, multiple subsequent studies evaluating the potential risk factors for\u00a0developing LE have reported that the disorder is more likely\u00a0in women in their sixth decade and\u00a0is significantly associated with underlying GERD, primary motility disorders such as achalasia, a history of tobacco use, certain allergies, hypothyroidism and the use of aspirin or statin medications. [8] [9] [10] [11] [12]"}
{"id": "article-155518_7", "title": "Lymphocytic Esophagitis -- Pathophysiology", "content": "The pathogenesis of\u00a0LE\u00a0is not well understood. The development of\u00a0LE has been hypothesized to occur secondary to either a hypersensitivity reaction to an ingestant or an underlying autoimmune phenomenon. [13] [14] [15] Authors of a case series of 42 patients with LE refuted hypotheses suggesting an association of\u00a0LE with any medication, concurrent disease, or allergies. [14] The histological pattern reported by Rubio et al in their original study reported increased expression of CD3, CD4, and CD8 proteins by esophageal intraepithelial lymphocytes. [1]", "contents": "Lymphocytic Esophagitis -- Pathophysiology. The pathogenesis of\u00a0LE\u00a0is not well understood. The development of\u00a0LE has been hypothesized to occur secondary to either a hypersensitivity reaction to an ingestant or an underlying autoimmune phenomenon. [13] [14] [15] Authors of a case series of 42 patients with LE refuted hypotheses suggesting an association of\u00a0LE with any medication, concurrent disease, or allergies. [14] The histological pattern reported by Rubio et al in their original study reported increased expression of CD3, CD4, and CD8 proteins by esophageal intraepithelial lymphocytes. [1]"}
{"id": "article-155518_8", "title": "Lymphocytic Esophagitis -- Pathophysiology", "content": "A 36-month observational study by Xue et al of esophageal biopsies\u00a0from 45 patients with\u00a0LE\u00a0reported that increased expression of CD4 by intraepithelial lymphocytes had a significantly higher prevalence of primary motility abnormalities compared to patients with CD8 predominant LE. [16] Another study by Putra et al reported a strong association\u00a0between\u00a0LE\u00a0and non-achalasia primary esophageal motility disorders with an odds ratio of 7.72 (95% CI, 2.26-27.9). [9]", "contents": "Lymphocytic Esophagitis -- Pathophysiology. A 36-month observational study by Xue et al of esophageal biopsies\u00a0from 45 patients with\u00a0LE\u00a0reported that increased expression of CD4 by intraepithelial lymphocytes had a significantly higher prevalence of primary motility abnormalities compared to patients with CD8 predominant LE. [16] Another study by Putra et al reported a strong association\u00a0between\u00a0LE\u00a0and non-achalasia primary esophageal motility disorders with an odds ratio of 7.72 (95% CI, 2.26-27.9). [9]"}
{"id": "article-155518_9", "title": "Lymphocytic Esophagitis -- Histopathology", "content": "Lymphocytic esophagitis is a histologic diagnosis. However, there is no consensus on the minimal number of intraepithelial lymphocytes required to diagnose LE. The 3 histologic findings widely recognized\u00a0as characteristic of\u00a0LE include\u00a0peripapillary lymphocytosis, marked spongiosis or intercellular edema, and the absence or minimal presence of intraepithelial granulocytes such as neutrophils or eosinophils in the absence of any apparent infectious etiology. [17] Spongiosis, found in many forms of esophagitis, has been noted as directly proportional to the degree of lymphocytosis. [3] [18]", "contents": "Lymphocytic Esophagitis -- Histopathology. Lymphocytic esophagitis is a histologic diagnosis. However, there is no consensus on the minimal number of intraepithelial lymphocytes required to diagnose LE. The 3 histologic findings widely recognized\u00a0as characteristic of\u00a0LE include\u00a0peripapillary lymphocytosis, marked spongiosis or intercellular edema, and the absence or minimal presence of intraepithelial granulocytes such as neutrophils or eosinophils in the absence of any apparent infectious etiology. [17] Spongiosis, found in many forms of esophagitis, has been noted as directly proportional to the degree of lymphocytosis. [3] [18]"}
{"id": "article-155518_10", "title": "Lymphocytic Esophagitis -- History and Physical", "content": "In contrast to eosinophilic esophagitis, usually diagnosed in young adult men, LE is predominantly seen in women in the sixth decade of life. The common presenting symptoms of LE include dysphagia, heartburn, or chest pain; nonspecific abdominal pain and nausea with or without vomiting have also been reported. [3] [10] A meta-analysis from 2019 identified that most patients with LE were women presenting with dysphagia. [12]", "contents": "Lymphocytic Esophagitis -- History and Physical. In contrast to eosinophilic esophagitis, usually diagnosed in young adult men, LE is predominantly seen in women in the sixth decade of life. The common presenting symptoms of LE include dysphagia, heartburn, or chest pain; nonspecific abdominal pain and nausea with or without vomiting have also been reported. [3] [10] A meta-analysis from 2019 identified that most patients with LE were women presenting with dysphagia. [12]"}
{"id": "article-155518_11", "title": "Lymphocytic Esophagitis -- History and Physical", "content": "A study of more than 100 patients with a histologic diagnosis of LE concluded that while most patients presented with clinical symptoms similar to eosinophilic esophagitis, they lacked the characteristic endoscopic features of that disease, including distinctive rings and furrows. [4]", "contents": "Lymphocytic Esophagitis -- History and Physical. A study of more than 100 patients with a histologic diagnosis of LE concluded that while most patients presented with clinical symptoms similar to eosinophilic esophagitis, they lacked the characteristic endoscopic features of that disease, including distinctive rings and furrows. [4]"}
{"id": "article-155518_12", "title": "Lymphocytic Esophagitis -- History and Physical", "content": "A single-center retrospective study evaluating the prevalence of eosinophilic esophagitis and\u00a0LE in adults presenting with esophageal food bolus impaction demonstrated that 17% of the total 228 participating patients had features of both eosinophilic esophagitis and LE and 9% of patients had evidence of only LE, implicating food bolus impaction as the presenting feature of LE. [19]", "contents": "Lymphocytic Esophagitis -- History and Physical. A single-center retrospective study evaluating the prevalence of eosinophilic esophagitis and\u00a0LE in adults presenting with esophageal food bolus impaction demonstrated that 17% of the total 228 participating patients had features of both eosinophilic esophagitis and LE and 9% of patients had evidence of only LE, implicating food bolus impaction as the presenting feature of LE. [19]"}
{"id": "article-155518_13", "title": "Lymphocytic Esophagitis -- Evaluation", "content": "An endoscopic esophageal biopsy is required to obtain the necessary tissue sample to diagnose LE histologically. However, unlike eosinophilic esophagitis, there are no guidelines\u00a0for a formal biopsy protocol when diagnosing LE.", "contents": "Lymphocytic Esophagitis -- Evaluation. An endoscopic esophageal biopsy is required to obtain the necessary tissue sample to diagnose LE histologically. However, unlike eosinophilic esophagitis, there are no guidelines\u00a0for a formal biopsy protocol when diagnosing LE."}
{"id": "article-155518_14", "title": "Lymphocytic Esophagitis -- Evaluation -- Esophagogastroduodenoscopy", "content": "The gross endoscopic features of LE vary widely. They may range from a normal-appearing esophagus to findings of esophageal strictures\u00a0or rings, linear furrows, erosive esophagitis, esophageal edema, or white plaques. [3] [10] With conventional endoscopy evaluation, as many as 23% to 55% of patients with histologic LE will have normal esophageal mucosa. [1] [4]", "contents": "Lymphocytic Esophagitis -- Evaluation -- Esophagogastroduodenoscopy. The gross endoscopic features of LE vary widely. They may range from a normal-appearing esophagus to findings of esophageal strictures\u00a0or rings, linear furrows, erosive esophagitis, esophageal edema, or white plaques. [3] [10] With conventional endoscopy evaluation, as many as 23% to 55% of patients with histologic LE will have normal esophageal mucosa. [1] [4]"}
{"id": "article-155518_15", "title": "Lymphocytic Esophagitis -- Evaluation -- Esophagogastroduodenoscopy", "content": "Using narrow-band imaging magnifying endoscopy (NBI-ME), Tanaka et al aimed to\u00a0distinguish the gross endoscopic features of LE, GERD, and eosinophilic esophagitis. Studied features included the presence of invisible submucosal vessels, beige-colored esophageal mucosa, and increased numbers of dot-shaped congested intrapapillary loops. Only 82% of patients in the\u00a0LE cohort demonstrated all three features compared to 100% of patients in the eosinophilic esophagitis cohort. [20]", "contents": "Lymphocytic Esophagitis -- Evaluation -- Esophagogastroduodenoscopy. Using narrow-band imaging magnifying endoscopy (NBI-ME), Tanaka et al aimed to\u00a0distinguish the gross endoscopic features of LE, GERD, and eosinophilic esophagitis. Studied features included the presence of invisible submucosal vessels, beige-colored esophageal mucosa, and increased numbers of dot-shaped congested intrapapillary loops. Only 82% of patients in the\u00a0LE cohort demonstrated all three features compared to 100% of patients in the eosinophilic esophagitis cohort. [20]"}
{"id": "article-155518_16", "title": "Lymphocytic Esophagitis -- Evaluation -- Esophagogastroduodenoscopy", "content": "There is no consensus on the minimal number of lymphocytes per high-power field\u00a0required to diagnose LE. However, esophageal biopsies demonstrating a histological pattern of more than 20 intraepithelial lymphocytes per high-power field,\u00a0few or absent granulocytes, and mucosal injury such as spongiosis have been accepted widely as diagnostic criteria. [5]", "contents": "Lymphocytic Esophagitis -- Evaluation -- Esophagogastroduodenoscopy. There is no consensus on the minimal number of lymphocytes per high-power field\u00a0required to diagnose LE. However, esophageal biopsies demonstrating a histological pattern of more than 20 intraepithelial lymphocytes per high-power field,\u00a0few or absent granulocytes, and mucosal injury such as spongiosis have been accepted widely as diagnostic criteria. [5]"}
{"id": "article-155518_17", "title": "Lymphocytic Esophagitis -- Evaluation -- Radiographic Studies", "content": "Radiographic studies such as barium esophagram\u00a0can evaluate for structural causes of dysphagia, including moderate-to-severe esophagitis, esophageal strictures, hiatal hernia, and neoplasms. However, the role of radiographic studies\u00a0in diagnosing\u00a0LE is limited.", "contents": "Lymphocytic Esophagitis -- Evaluation -- Radiographic Studies. Radiographic studies such as barium esophagram\u00a0can evaluate for structural causes of dysphagia, including moderate-to-severe esophagitis, esophageal strictures, hiatal hernia, and neoplasms. However, the role of radiographic studies\u00a0in diagnosing\u00a0LE is limited."}
{"id": "article-155518_18", "title": "Lymphocytic Esophagitis -- Evaluation -- Other Studies", "content": "Patients with a confirmed histologic diagnosis of\u00a0LE without gross endoscopic structural abnormalities should be evaluated for underlying achalasia and non-achalasia primary esophageal motility disorders using high-resolution esophageal manometry (HREM), given the significant association between motility disorders and LE. These patients also require laboratory evaluation for rheumatological and autoimmune diseases if the medical history and physical examination support such a diagnosis.", "contents": "Lymphocytic Esophagitis -- Evaluation -- Other Studies. Patients with a confirmed histologic diagnosis of\u00a0LE without gross endoscopic structural abnormalities should be evaluated for underlying achalasia and non-achalasia primary esophageal motility disorders using high-resolution esophageal manometry (HREM), given the significant association between motility disorders and LE. These patients also require laboratory evaluation for rheumatological and autoimmune diseases if the medical history and physical examination support such a diagnosis."}
{"id": "article-155518_19", "title": "Lymphocytic Esophagitis -- Treatment / Management", "content": "The management of\u00a0LE\u00a0remains ill-defined due to a lack of clinical guidelines. Current management strategies for LE mimic those of eosinophilic esophagitis\u00a0due to the clinical and endoscopic similarities of the two disease processes. However, LE is more likely to respond to medical therapy than eosinophilic esophagitis. [8] Unlike eosinophilic esophagitis, the role of systemic steroids and biologic therapy has not been studied in patients with LE.", "contents": "Lymphocytic Esophagitis -- Treatment / Management. The management of\u00a0LE\u00a0remains ill-defined due to a lack of clinical guidelines. Current management strategies for LE mimic those of eosinophilic esophagitis\u00a0due to the clinical and endoscopic similarities of the two disease processes. However, LE is more likely to respond to medical therapy than eosinophilic esophagitis. [8] Unlike eosinophilic esophagitis, the role of systemic steroids and biologic therapy has not been studied in patients with LE."}
{"id": "article-155518_20", "title": "Lymphocytic Esophagitis -- Treatment / Management -- Lifestyle Modifications", "content": "Patients with LE who use tobacco should receive education and support regarding tobacco cessation.", "contents": "Lymphocytic Esophagitis -- Treatment / Management -- Lifestyle Modifications. Patients with LE who use tobacco should receive education and support regarding tobacco cessation."}
{"id": "article-155518_21", "title": "Lymphocytic Esophagitis -- Treatment / Management -- Medical Management", "content": "Medical management of LE comprises high-dose proton pump inhibitor (PPI) therapy twice daily for 12 weeks. Changes in symptomatology or endoscopic findings should be assessed after this course of therapy. If no clinical or histologic improvement is achieved with high-dose PPI therapy, topical steroids such as\u00a0budesonide\u00a01 mg twice daily are recommended. Most patients report improved\u00a0symptoms with the initiation of PPI therapy. However, it is unclear if the symptomatic improvement is secondary to the treatment of underlying GERD. [17] In a small study of 22 patients with a confirmed diagnosis of LE, histological remission was achieved in 40% of patients with a course of high-dose PPI therapy; given the small sample size, further studies are needed. [17] [14]", "contents": "Lymphocytic Esophagitis -- Treatment / Management -- Medical Management. Medical management of LE comprises high-dose proton pump inhibitor (PPI) therapy twice daily for 12 weeks. Changes in symptomatology or endoscopic findings should be assessed after this course of therapy. If no clinical or histologic improvement is achieved with high-dose PPI therapy, topical steroids such as\u00a0budesonide\u00a01 mg twice daily are recommended. Most patients report improved\u00a0symptoms with the initiation of PPI therapy. However, it is unclear if the symptomatic improvement is secondary to the treatment of underlying GERD. [17] In a small study of 22 patients with a confirmed diagnosis of LE, histological remission was achieved in 40% of patients with a course of high-dose PPI therapy; given the small sample size, further studies are needed. [17] [14]"}
{"id": "article-155518_22", "title": "Lymphocytic Esophagitis -- Treatment / Management -- Endoscopic Therapeutic Interventions", "content": "Serial endoscopic dilatation is advised for patients with LE with persistent symptomatic esophageal strictures or rings despite medical therapy. [21]", "contents": "Lymphocytic Esophagitis -- Treatment / Management -- Endoscopic Therapeutic Interventions. Serial endoscopic dilatation is advised for patients with LE with persistent symptomatic esophageal strictures or rings despite medical therapy. [21]"}
{"id": "article-155518_23", "title": "Lymphocytic Esophagitis -- Differential Diagnosis", "content": "The differential diagnosis of LE includes but is not limited to the following disease processes: Gastroesophageal reflux disease Erosive esophagitis Candida esophagitis Eosinophilic esophagitis Esophageal lichen planus Achalasia Non-achalasia esophageal motility disorder Peptic stricture Esophageal neoplasm IgG4-related esophagitis", "contents": "Lymphocytic Esophagitis -- Differential Diagnosis. The differential diagnosis of LE includes but is not limited to the following disease processes: Gastroesophageal reflux disease Erosive esophagitis Candida esophagitis Eosinophilic esophagitis Esophageal lichen planus Achalasia Non-achalasia esophageal motility disorder Peptic stricture Esophageal neoplasm IgG4-related esophagitis"}
{"id": "article-155518_24", "title": "Lymphocytic Esophagitis -- Prognosis", "content": "Data\u00a0delineating the natural history of\u00a0LE are scarce. However, based on the described responses to conventional high-dose PPI medical therapy, the disease runs a chronic but benign course. [2] A retrospective study by Cohen et al\u00a0of 81 patients with LE\u00a0indicated that most patients\u00a0report a good quality of life. [2] Early diagnosis of LE and monitoring for complications such as esophageal strictures are crucial to prevent long-term morbidity.", "contents": "Lymphocytic Esophagitis -- Prognosis. Data\u00a0delineating the natural history of\u00a0LE are scarce. However, based on the described responses to conventional high-dose PPI medical therapy, the disease runs a chronic but benign course. [2] A retrospective study by Cohen et al\u00a0of 81 patients with LE\u00a0indicated that most patients\u00a0report a good quality of life. [2] Early diagnosis of LE and monitoring for complications such as esophageal strictures are crucial to prevent long-term morbidity."}
{"id": "article-155518_25", "title": "Lymphocytic Esophagitis -- Complications", "content": "The complications of LE include esophageal strictures, webs, and perforation.", "contents": "Lymphocytic Esophagitis -- Complications. The complications of LE include esophageal strictures, webs, and perforation."}
{"id": "article-155518_26", "title": "Lymphocytic Esophagitis -- Deterrence and Patient Education", "content": "Modifiable risk factors for the development of LE include tobacco use and underlying GERD. Patients with LE who use tobacco products should receive education and support regarding tobacco cessation.", "contents": "Lymphocytic Esophagitis -- Deterrence and Patient Education. Modifiable risk factors for the development of LE include tobacco use and underlying GERD. Patients with LE who use tobacco products should receive education and support regarding tobacco cessation."}
{"id": "article-155518_27", "title": "Lymphocytic Esophagitis -- Deterrence and Patient Education", "content": "Medical management of LE should include high-dose PPI therapy; this regimen should also address any symptoms caused by underlying GERD. Additionally, patients should be educated on lifestyle modifications to reduce GERD. These modifications may include avoiding foods that trigger reflux symptoms, waiting three hours after eating before reclining, avoiding late-night snacks, and elevating the head of the bed during sleep.", "contents": "Lymphocytic Esophagitis -- Deterrence and Patient Education. Medical management of LE should include high-dose PPI therapy; this regimen should also address any symptoms caused by underlying GERD. Additionally, patients should be educated on lifestyle modifications to reduce GERD. These modifications may include avoiding foods that trigger reflux symptoms, waiting three hours after eating before reclining, avoiding late-night snacks, and elevating the head of the bed during sleep."}
{"id": "article-155518_28", "title": "Lymphocytic Esophagitis -- Deterrence and Patient Education", "content": "Patients should be educated that while LE is a chronic disease, it is benign and not life-threatening. Patients should be encouraged to adhere to medical management and lifestyle modification strategies, monitor their symptoms, and attend all follow-up appointments, including those for repeat endoscopic evaluation and possible biopsy.", "contents": "Lymphocytic Esophagitis -- Deterrence and Patient Education. Patients should be educated that while LE is a chronic disease, it is benign and not life-threatening. Patients should be encouraged to adhere to medical management and lifestyle modification strategies, monitor their symptoms, and attend all follow-up appointments, including those for repeat endoscopic evaluation and possible biopsy."}
{"id": "article-155518_29", "title": "Lymphocytic Esophagitis -- Enhancing Healthcare Team Outcomes", "content": "Most patients with symptoms of dysphagia and food impaction will present to their primary care practitioner for evaluation and management. However, given the limited understanding of LE and its variable clinical presentation, primary care practitioners should engage the consultative services of a gastroenterologist if gastrointestinal symptoms do not completely resolve in response to lifestyle modifications and routine medical management of GERD. Close collaboration between gastroenterologists and pathologists is required to arrive at a diagnosis of LE. Clinical nursing staff plays a critical role in ensuring patients understand the necessary lifestyle modifications to manage LE and understand the necessity for committing to all follow-up appointments.", "contents": "Lymphocytic Esophagitis -- Enhancing Healthcare Team Outcomes. Most patients with symptoms of dysphagia and food impaction will present to their primary care practitioner for evaluation and management. However, given the limited understanding of LE and its variable clinical presentation, primary care practitioners should engage the consultative services of a gastroenterologist if gastrointestinal symptoms do not completely resolve in response to lifestyle modifications and routine medical management of GERD. Close collaboration between gastroenterologists and pathologists is required to arrive at a diagnosis of LE. Clinical nursing staff plays a critical role in ensuring patients understand the necessary lifestyle modifications to manage LE and understand the necessity for committing to all follow-up appointments."}
{"id": "article-155518_30", "title": "Lymphocytic Esophagitis -- Enhancing Healthcare Team Outcomes", "content": "More extensive prospective studies evaluating the natural history of LE with long-term follow-up are needed to understand the condition. Further research could help clinicians tailor care to\u00a0improve outcomes with this specific disease process.", "contents": "Lymphocytic Esophagitis -- Enhancing Healthcare Team Outcomes. More extensive prospective studies evaluating the natural history of LE with long-term follow-up are needed to understand the condition. Further research could help clinicians tailor care to\u00a0improve outcomes with this specific disease process."}
{"id": "article-155518_31", "title": "Lymphocytic Esophagitis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Lymphocytic Esophagitis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}